Cyclooxygenase-2 and Cytosolic Phospholipase A2 Are Overexpressed in Mucinous Pancreatic Cysts
暂无分享,去创建一个
B. Petersen | M. Kendrick | T. Smyrk | S. Chari | N. Buttar | B. Bick | F. Enders | R. Pearson | S. Vege | Lizhi Zhang | M. Levy | F. Gleeson | P. Limburg | M. Topazian | C. Wood‐Wentz | E. T. Mensah
[1] J. Manson,et al. Regular Use of Aspirin or Non-Aspirin Nonsteroidal Anti-Inflammatory Drugs Is Not Associated With Risk of Incident Pancreatic Cancer in Two Large Cohort Studies. , 2018, Gastroenterology.
[2] S. Ching,et al. Effects of chemopreventive agents on the incidence of recurrent colorectal adenomas: a systematic review with network meta-analysis of randomized controlled trials , 2017, OncoTargets and therapy.
[3] J. Akiyama,et al. Effect of low-dose aspirin use on pancreatic cancer development and morphological changes on imaging in IPMN: A long-term cohort study , 2017, United European gastroenterology journal.
[4] A. Abdollahi,et al. K-Ras and cyclooxygenase-2 coactivation augments intraductal papillary mucinous neoplasm and Notch1 mimicking human pancreas lesions , 2016, Scientific Reports.
[5] A. Krasinskas,et al. A Revised Classification System and Recommendations From the Baltimore Consensus Meeting for Neoplastic Precursor Lesions in the Pancreas , 2015, The American journal of surgical pathology.
[6] Linda S. Lee,et al. Pancreatic Juice Prostaglandin E2 Concentrations Are Elevated in Chronic Pancreatitis and Improve Detection of Early Disease , 2015, Clinical and Translational Gastroenterology.
[7] R. Hwang,et al. Prostaglandin E2 Regulates Pancreatic Stellate Cell Activity Via the EP4 Receptor , 2013, Pancreas.
[8] J. Vallés,et al. Reduction of platelet cytosolic phospholipase A2 activity by atorvastatin and simvastatin: biochemical regulatory mechanisms. , 2013, Thrombosis research.
[9] Jin-Young Jang,et al. International consensus guidelines 2012 for the management of IPMN and MCN of the pancreas. , 2012, Pancreatology : official journal of the International Association of Pancreatology (IAP) ... [et al.].
[10] Richard S. Kwon,et al. A randomized trial of rectal indomethacin to prevent post-ERCP pancreatitis. , 2012, The New England journal of medicine.
[11] N. Rofsky,et al. Prevalence of Incidental Pancreatic Cysts in the Adult Population on MR Imaging , 2010, The American Journal of Gastroenterology.
[12] Krishna Kadaveru,et al. cPLA2 is protective against COX inhibitor-induced intestinal damage. , 2010, Toxicological sciences : an official journal of the Society of Toxicology.
[13] Seung‐Mo Hong,et al. Cyclooxygenase-Deficient Pancreatic Cancer Cells Use Exogenous Sources of Prostaglandins , 2010, Molecular Cancer Research.
[14] R. DuBois,et al. Eicosanoids and cancer , 2010, Nature Reviews Cancer.
[15] C. Schmidt,et al. Cyclooxygenase-2 expression in hamster and human pancreatic neoplasia. , 2006, Neoplasia.
[16] S. Gansauge,et al. Cyclooxygenase-2 is Overexpressed in Chronic Pancreatitis , 2002, Pancreas.
[17] H. Friess,et al. Cyclooxygenase 2 Expression in Chronic Pancreatitis: Correlation with Stage of the Disease and Diabetes mellitus , 2001, Digestion.
[18] T. Fahey,et al. Cyclooxygenase-2 expression is up-regulated in human pancreatic cancer. , 1999, Cancer research.
[19] W. Remmele,et al. [Recommendation for uniform definition of an immunoreactive score (IRS) for immunohistochemical estrogen receptor detection (ER-ICA) in breast cancer tissue]. , 1987, Der Pathologe.